Lindane

Lindane

SCHEMBL713825

Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl.O=C(O)CCC(F)C(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

823298382338688239847Rdl1Rdl2Rdl3

The experimentally established mechanism targets of Lindane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TET2 Q6N021 3/20 0.43
KDM4A O75164 2/20 0.43
KDM4C Q9H3R0 2/20 0.43
KDM2A Q9Y2K7 2/20 0.43
TET3 O43151 1/20 0.43
FOLH1 Q04609 10/20 0.41
CYP1A2 P05177 2/20 0.41
GRM3 Q14832 2/20 0.41
GRM8 O00222 1/20 0.41
GRM6 O15303 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GSR P00390 1/20 0.41
GRIK1 P39086 1/20 0.41
GRM5 P41594 1/20 0.41
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2801076 0.89 TET2 (0.52) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL18334357 0.89 TET2 (0.52) TET2KDM4AKDM4CKDM2ATET3
Lindane SCHEMBL10587433 0.79 GABRP (0.35) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL18334377 0.75 MAPT (0.56) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL18334378 0.75 MAPT (0.56) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL22826568 0.73 MAPT (0.59) FOLH1MAPT
SCHEMBL30816384 0.71 MAPT (0.63) MAPT
SCHEMBL8639483 0.71 MAPT (0.63) MAPT
SCHEMBL3510953 0.70 KMT2A (0.56) FOLH1CYP1A2GRM3GRM8GRM6
SCHEMBL21443815 0.70 GABRP (0.46) TET2KDM4AKDM4CKDM2ATET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278909-B2 Amide-extended crosslinking compounds and methods for use thereof DESIGNER MOLECULES, INC. (US) 2016-03-08 US disclosed
US-8637611-B2 Amide-extended crosslinking compounds and methods for use thereof DESIGNER MOLECULES, INC. (US) 2014-01-28 US disclosed
US-20130338313-A1 AMIDE-EXTENDED CROSSLINKING COMPOUNDS AND METHODS FOR USE THEREOF DESIGNER MOLECULES, INC. (US) 2013-12-19 US disclosed
US-20130199724-A1 CURATIVES FOR EPOXY COMPOSITIONS DESIGNER MOLECULES, INC. (US) 2013-08-08 US disclosed
US-20130203895-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2013-08-08 US disclosed
US-20130012620-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2013-01-10 US disclosed
US-8288591-B2 Curing agents for epoxy resins DESIGNER MOLECULES, INC. (US) 2012-10-16 US disclosed
US-8287686-B2 Derivatives of poly(styrene-co-allyl alcohol) and methods for use thereof DESIGNER MOLECULES, INC. (US) 2012-10-16 US disclosed
US-8217120-B2 Functionalized styrene oligomers and polymers DESIGNER MOLECULES, INC. (US) 2012-07-10 US disclosed
US-20120049106-A1 MALEIMIDE-FUNCTIONAL MONOMERS IN AMORPHOUS FORM DESIGNER MOLECULES, INC. (US) 2012-03-01 US disclosed
WO-2010019832-A2 AMIDE-EXTENDED CROSSLINKING COMPOUNDS AND METHODS FOR USE THEREOF DESIGNER MOLECULES, INC. (US) 2010-02-18 WO disclosed
US-20100041823-A1 NOVEL SILOXANE MONOMERS AND METHODS FOR USE THEREOF DESIGNER MOLECULES, INC. (US) 2010-02-18 US disclosed
US-20100041803-A1 THERMOSETTING HYPERBRANCHED COMPOSITIONS AND METHODS FOR USE THEREOF DESIGNER MOLECULES, INC. (US) 2010-02-18 US disclosed
US-20100041832-A1 FUNCTIONALIZED STYRENE OLIGOMERS AND POLYMERS DESIGNER MOLECULES, INC. (US) 2010-02-18 US disclosed
US-20080017308-A1 Derivatives of poly(styrene-co-allyl alcohol) and methods for use thereof DESIGNER MOLECULES, INC. 2008-01-24 US disclosed
US-20070295454-A1 Reworkable compositions and methods for use thereof EDWARDS MAURY 2007-12-27 US disclosed
WO-2007142654-A1 REWORKABLE COMPOSITIONS AND METHODS FOR USE THEREOF ADVANCED APPLIED ADHESIVES (US) 2007-12-13 WO disclosed
US-20060069232-A1 Underfill compositions and methods for use thereof DESIGNER MOLECULES, INC. 2006-03-30 US disclosed
US-7009009-B1 Fluxing underfill compositions HENKEL CORPORATION (US) 2006-03-07 US disclosed
US-6667194-B1 Method of bonding die chip with underfill fluxing composition HENKEL LOCTITE CORPORATION 2003-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041823-A1 NOVEL SILOXANE MONOMERS AND METHODS FOR USE THEREOF ILK, ESD, GFER TET2 227/4885KDM4A 54/4885KDM4C 203/4885
US-20100041832-A1 FUNCTIONALIZED STYRENE OLIGOMERS AND POLYMERS PFAS, FDFT1, AOX1 TET2 318/4885KDM4A 1488/4885KDM4C 1670/4885
US-20130012620-A1 CURING AGENTS FOR EPOXY RESINS DOT1L, EHMT1, ASH1L TET2 215/4885KDM4A 14/4885KDM4C 13/4885
US-20100041803-A1 THERMOSETTING HYPERBRANCHED COMPOSITIONS AND METHODS FOR USE THEREOF PAICS, PUF60, PARG TET2 1219/4885KDM4A 839/4885KDM4C 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.